首页> 外文期刊>Vascular and endovascular surgery >Balloon-occlusion catheter rupture during balloon-occluded retrograde transvenous obliteration of gastric varices utilizing sodium tetradecyl sulfate: Incidence and consequences
【24h】

Balloon-occlusion catheter rupture during balloon-occluded retrograde transvenous obliteration of gastric varices utilizing sodium tetradecyl sulfate: Incidence and consequences

机译:利用十四烷基硫酸钠对胃底静脉曲张进行球囊闭塞逆行静脉闭塞术中的球囊闭塞导管破裂:发生率和后果

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Balloon-occluded retrograde transvenous obliteration (BRTO) is an established procedure for the management of bleeding gastric varices in Asia. Invariably, the sclerosant utilized in Asia is ethanolamine oleate and the inventory used (vascular sheaths, balloon-occlusion catheters, and microcatheters) is not available outside Asia. A total of 41 BRTO procedures were performed with a technical and obliterative (gastric varix obliteration) success rate of 95% (n = 39 of 41) and 85% (n = 35 of 41), respectively. Complications were 4.9% (n = 2/41). A total of 6 balloon ruptures occurred (14.6%, n = 6 of 41). One rupture (16.7%, n = 1 of 6 of ruptures) lead to a technical failure and 2 ruptures (33.3%, n = 2 of 6 of ruptures) lead to an obliterative failure. Balloon rupture contributed to 50% of technical failures (n = 1/2, P =.274) and 33% of obliteration failures (n = 2/6, P =.148). In conclusion, the incidence of balloon-occlusion catheter rupture utilizing 3% sodium tetradecyl sulfate (STS) and inventory unique to the United States is significantly higher than in Asia (<8% rupture rate). However, these ruptures have no significant technical or clinical consequences.
机译:球囊阻塞性逆行静脉闭塞术(BRTO)是亚洲治疗胃底静脉曲张破裂出血的既定程序。一直以来,亚洲使用的硬化剂是乙醇胺油酸酯,所使用的库存(血管鞘,气囊阻塞导管和微导管)在亚洲以外没有。总共进行了41次BRTO手术,技术性和通气性(胃静脉曲张闭塞)成功率分别为95%(n = 41的39)和85%(n = 41的35)。并发症发生率为4.9%(n = 2/41)。总共发生了6个球囊破裂(14.6%,n = 6/41)。一次破裂(16.7%,n = 6个破裂中的1个)会导致技术故障,而两次破裂(33.3%,n = 6个破裂中的2个)会导致闭塞性故障。球囊破裂占技术失败的50%(n = 1/2,P = .274)和闭塞失败的33%(n = 2/6,P = .148)。总之,美国使用3%的十四烷基硫酸钠(STS)和库存进行的球囊阻塞导管破裂的发生率显着高于亚洲(<8%破裂率)。但是,这些破裂没有重大的技术或临床后果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号